Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 357
- 试验地点
- 1
- 主要终点
- Quality of life of patients with a history of herpes zoster who attend the immunization unit of the Jiménez Díaz Foundation University Hospital.
研究概览
简要总结
Title: Impact on quality of life and disease burden in adults with herpes zoster
Prospective cohort study for the primary objective and the secondary objectives (1 and 2) and retrospective cohort study for the secondary objective 3.
Disease or disorder under study: Patients with a herpes zoster (HZ) diagnosis.
详细描述
Impact on quality of life and disease burden in adults with herpes zoster Contents
HYPOTHESIS AND OBJECTIVES OF THE STUDY 3.1 Hypothesis: Herpes zoster significantly affects the quality of life of those who suffer from it with a high disease burden.
3.2 Primary outcomes: To measure the quality of life of patients with a history of herpes zoster who attend the immunization unit of the Fundación Jiménez Díaz University Hospital.
3.3 Secondary outcomes
- Evaluating the quality of life according to the location of the zoster (postherpetic neuralgia, ophthalmic zoster, etc.)
- Evaluating the effectiveness of the vaccine against herpes zoster in terms of number of episodes, severity and quality of life.
- Evaluating the economic impact and disease burden in terms of morbidity and mortality in adult with herpes zoster
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Quality of life of patients with a history of herpes zoster who attend the immunization unit of the Jiménez Díaz Foundation University Hospital.
时间窗: Data will be collected for 1 year and then analyzed to respond to the outcomes
Measuring the quality of life of patients with a history of herpes zoster who attend the immunization unit of the Jiménez Díaz Foundation University Hospital.
次要结局
- Quality of life according to the location of herpes zoster(Data will be collected for 1 year and then analyzed to respond to the outcome)
- Effectiveness of the vaccine against herpes zoster(Data will be collected for 1 year and then analyzed to respond to the objective)
- Economic impact and disease burden in terms of morbidity and mortality(A retrospective analysis will be carried out, when the data has been analysed this outcome will be answered, in approximately 6 months.)